fibromyalgia and glp-1 Pain: The Next Frontier for RAs? Fibromyalgia and Semaglutide: Patient Outcomes

Similar effects have been noted in patients who are not on GLP-1 medication but who switch to anti-inflammatory diets focused on eating whole foods

We prioritize regular monitoring and personalized treatment adjustments to achieve optimal results and meet each clients unique weight loss goals

Glucagon-Like Peptide-1 (GLP-1) is a naturally occurring hormone that regulates blood sugar levels, appetite, and digestion

On average, patients who respond well to Ozempic as a weight loss treatment will lose around 6% of their body weight within the first year of taking the medication, with those who continue taking it for at least 18 months being able to lose closer to 1015% of their body weight